A detailed history of Wellington Management Group LLP transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Wellington Management Group LLP holds 4,178,788 shares of PRTA stock, worth $54.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,178,788
Previous 3,639,429 14.82%
Holding current value
$54.5 Million
Previous $75.1 Million 6.93%
% of portfolio
0.01%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$16.73 - $24.79 $9.02 Million - $13.4 Million
539,359 Added 14.82%
4,178,788 $69.9 Million
Q2 2024

Aug 13, 2024

SELL
$19.54 - $26.15 $2.2 Million - $2.95 Million
-112,718 Reduced 3.0%
3,639,429 $75.1 Million
Q1 2024

May 15, 2024

BUY
$24.75 - $40.66 $92.9 Million - $153 Million
3,752,147 New
3,752,147 $92.9 Million
Q4 2023

Feb 12, 2024

BUY
$32.31 - $52.32 $83.8 Million - $136 Million
2,594,102 New
2,594,102 $94.3 Million
Q3 2023

Nov 14, 2023

SELL
$47.3 - $70.6 $3.29 Million - $4.91 Million
-69,575 Reduced 3.15%
2,141,647 $103 Million
Q2 2023

Aug 14, 2023

SELL
$48.26 - $78.59 $2.65 Million - $4.31 Million
-54,856 Reduced 2.42%
2,211,222 $151 Million
Q1 2023

May 12, 2023

BUY
$46.97 - $58.27 $23.5 Million - $29.2 Million
501,185 Added 28.4%
2,266,078 $110 Million
Q4 2022

Feb 13, 2023

BUY
$52.05 - $65.0 $69.4 Million - $86.7 Million
1,333,384 Added 309.0%
1,764,893 $106 Million
Q3 2022

Nov 14, 2022

BUY
$25.16 - $60.63 $8.51 Million - $20.5 Million
338,055 Added 361.73%
431,509 $26.2 Million
Q2 2022

Aug 15, 2022

SELL
$22.73 - $39.98 $727 - $1,279
-32 Reduced 0.03%
93,454 $2.54 Million
Q1 2022

May 16, 2022

BUY
$30.27 - $49.22 $4,449 - $7,235
147 Added 0.16%
93,486 $3.42 Million
Q4 2021

Feb 11, 2022

BUY
$42.11 - $73.26 $3.93 Million - $6.84 Million
93,339 New
93,339 $4.61 Million
Q3 2021

Nov 15, 2021

SELL
$48.2 - $78.89 $1.15 Million - $1.88 Million
-23,821 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$21.63 - $57.65 $69,908 - $186,324
3,232 Added 15.7%
23,821 $1.22 Million
Q1 2021

May 17, 2021

SELL
$11.0 - $28.24 $2.25 Million - $5.77 Million
-204,144 Reduced 90.84%
20,589 $517,000
Q4 2020

Feb 12, 2021

SELL
$10.12 - $13.94 $3.86 Million - $5.32 Million
-381,533 Reduced 62.93%
224,733 $2.7 Million
Q3 2020

Nov 16, 2020

SELL
$9.93 - $13.47 $2.97 Million - $4.03 Million
-299,319 Reduced 33.05%
606,266 $6.06 Million
Q2 2020

Aug 14, 2020

SELL
$9.56 - $12.51 $241,017 - $315,389
-25,211 Reduced 2.71%
905,585 $9.47 Million
Q1 2020

May 14, 2020

SELL
$7.54 - $15.77 $325,004 - $679,750
-43,104 Reduced 4.43%
930,796 $9.96 Million
Q4 2019

Feb 11, 2020

BUY
$7.48 - $17.01 $7.28 Million - $16.6 Million
973,900 New
973,900 $15.4 Million

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $612M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.